CAMP FY 2013 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

FY 2013 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$236M+30.6% YoY

Gross Profit

$80M33.9% margin

Operating Income

$18M7.8% margin

Net Income

$12M5.0% margin

EPS (Diluted)

$0.33

Cash Flow

Operating Cash Flow

$23M

Free Cash Flow

$21M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$179M

Total Liabilities

$46M

Stockholders' Equity

$133M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$236M	$181M	+30.6%
Gross Profit	$80M	$57M	+40.5%
Operating Income	$18M	$16M	+14.8%
Net Income	$12M	$45M	-73.6%